ADIL
Price
$0.32
Change
-$0.01 (-3.03%)
Updated
Jul 8 closing price
Capitalization
5.02M
BPMUF
Price
$61.34
Change
+$3.64 (+6.31%)
Updated
Jul 1 closing price
Capitalization
731.76M
Interact to see
Advertisement

ADIL vs BPMUF

Header iconADIL vs BPMUF Comparison
Open Charts ADIL vs BPMUFBanner chart's image
Adial Pharmaceuticals
Price$0.32
Change-$0.01 (-3.03%)
Volume$1.55M
Capitalization5.02M
Basilea Pharmaceutica AG
Price$61.34
Change+$3.64 (+6.31%)
Volume$7
Capitalization731.76M
ADIL vs BPMUF Comparison Chart in %
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. BPMUF commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a StrongBuy and BPMUF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (ADIL: $0.32 vs. BPMUF: $61.34)
Brand notoriety: ADIL and BPMUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 14% vs. BPMUF: 50%
Market capitalization -- ADIL: $5.02M vs. BPMUF: $731.76M
ADIL [@Biotechnology] is valued at $5.02M. BPMUF’s [@Biotechnology] market capitalization is $731.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileBPMUF’s FA Score has 0 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • BPMUF’s FA Score: 0 green, 5 red.
According to our system of comparison, ADIL is a better buy in the long-term than BPMUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 6 TA indicator(s) are bullish while BPMUF’s TA Score has 4 bullish TA indicator(s).

  • ADIL’s TA Score: 6 bullish, 4 bearish.
  • BPMUF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ADIL is a better buy in the short-term than BPMUF.

Price Growth

ADIL (@Biotechnology) experienced а +0.54% price change this week, while BPMUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

ADIL is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($732M) has a higher market cap than ADIL($5.02M). BPMUF YTD gains are higher at: 16.108 vs. ADIL (-68.515). BPMUF has higher annual earnings (EBITDA): -4.5M vs. ADIL (-8.71M). BPMUF has more cash in the bank: 63M vs. ADIL (2.37M). ADIL has less debt than BPMUF: ADIL (194K) vs BPMUF (112M). BPMUF has higher revenues than ADIL: BPMUF (149M) vs ADIL (0).
ADILBPMUFADIL / BPMUF
Capitalization5.02M732M1%
EBITDA-8.71M-4.5M193%
Gain YTD-68.51516.108-425%
P/E RatioN/A8.36-
Revenue0149M-
Total Cash2.37M63M4%
Total Debt194K112M0%
FUNDAMENTALS RATINGS
ADIL vs BPMUF: Fundamental Ratings
ADIL
BPMUF
OUTLOOK RATING
1..100
8442
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
9747
P/E GROWTH RATING
1..100
60100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADIL's Valuation (31) in the Pharmaceuticals Major industry is somewhat better than the same rating for BPMUF (77) in the null industry. This means that ADIL’s stock grew somewhat faster than BPMUF’s over the last 12 months.

BPMUF's Profit vs Risk Rating (68) in the null industry is in the same range as ADIL (100) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew similarly to ADIL’s over the last 12 months.

BPMUF's SMR Rating (91) in the null industry is in the same range as ADIL (99) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew similarly to ADIL’s over the last 12 months.

BPMUF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for ADIL (97) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew somewhat faster than ADIL’s over the last 12 months.

ADIL's P/E Growth Rating (60) in the Pharmaceuticals Major industry is somewhat better than the same rating for BPMUF (100) in the null industry. This means that ADIL’s stock grew somewhat faster than BPMUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADILBPMUF
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
13%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
19%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
22%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
11%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFAZX12.030.04
+0.33%
Applied Finance Dividend Institutional
MTRRX19.82N/A
N/A
MFS Total Return R2
DSMFX13.46N/A
N/A
Destinations Small-Mid Cap Equity I
FIFPX24.06N/A
N/A
Fidelity Advisor Founders M
NRAEX51.87N/A
N/A
Neuberger Berman Sustainable Equity E

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
-2.33%
SYRE - ADIL
39%
Loosely correlated
+2.03%
VANI - ADIL
37%
Loosely correlated
N/A
VTVT - ADIL
29%
Poorly correlated
+7.45%
BPMUF - ADIL
28%
Poorly correlated
N/A
GDTC - ADIL
27%
Poorly correlated
+6.59%
More

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
+2.43%
GTBP - BPMUF
29%
Poorly correlated
-5.53%
NCNA - BPMUF
28%
Poorly correlated
+11.42%
More